Center for Medicines in the Public Interest

Center for Medicines in the Public Interest

New York, NY 10017
Tax ID20-4321812

Want to make a donation using Daffy?

Lower your income taxes with a charitable deduction this year when you donate to this non-profit via Daffy.

Payment method

Frequency

Amount

$USD
Daffy covers all ACH transaction fees so 100% of your donation goes to your favorite charities.

Do you work for Center for Medicines in the Public Interest? Learn more here.

About this organization

Revenue

$714,553

Expenses

$733,734

Website

cmpi.org

Mission

THE COMMUNICATION OF IDEAS THAT FOCUS ON UNDERSTANDING MEDICAL INNOVATION TO EFFECT CHANGE IN PUBLIC HEALTH CARE POLICY.

About

THE ORGANIZATION PARTICIPATED IN CONFERENCES AND MEETINGS INCLUDING: BEST CONFERENCE ON PHARMACEUTICAL INNOVATION ON JANUARY 17TH, LECTURE AT MT. SINAI MEDICAL SCHOOL ON HEALTHCARE POLICY ON FEBRUARY 21ST, MEETING WITH HONG KONG HEALTH AUTHORITY ON REAL WORLD EVIDENCE DEVELOPMENT ON FEBRUARY 26TH, MEETING AT THE FDA ON BIOSIMILARS ON ARIL 11TH, ANNUAL FDLI CONFERENCE IN WASHINGTON, DC ON MAY 3RD, ISPOR CONFERENCE PANEL ON REAL WORLD EVIDENCE ON MAY 19TH, BIO CONFERENCE IN BOSTON, MA ON JUNE 5TH, FIFTH NATIONAL CONFERENCE ON MEDICAL DEVICES IN SAN FRANCISCO, CA ON JUNE 7TH, ANNUAL ANVISA CONFERENCE KEYNOTE SPEECH ON REAL WORLD EVIDENCE IN BRAZIL ON JUNE 12TH, MEETING AT PHRMA ON WHITE HOUSE BLUEPRINT RFI RESPONSES IN WASHINGTON, DC ON JUNE 21ST, CMPI CONFERENCE ON ABUSE-DETERRENT OPIOIDS IN WASHINGTON, DC ON AUGUST 17TH, FDA SEMINAR ON 21ST CENTURY PHARMACOVIGILANCE IN WASHINGTON, DC ON SEPTEMBER 11TH, SAUDI FDA ANNUAL CONFERENCE IN RIYADH, SAUDI ARABIA ON SEPTEMBER 25TH, NY GENOME CENTER CONFERENCE ON 21ST CENTURY BIOTECHNOLOGY IN NEW YORK ON OCTOBER 15TH, CANCER PATIENT EMPOWERMENT CONFERENCE IN RIO DE JANIERO, BRAZIL ON OCTOBER 23RD, EXPANDED ACCESS CONFERENCE IN WASHINGTON, DC ON OCTOBER 29TH, A SUMMIT EXPLORING 3D PRINTED PHARMACEUTICALS ON NOVEMBER 8, 2018, CONFERENCE ON PATIENT REPORTED OUTCOMES AND REAL WORK EVIDENCE IN PARIS, FRANCE ON DECEMBER 17TH.

Interesting data from their 2020 990 filing

The mission of the non-profit, as stated in the filing, is “The communication of ideas that focus on understanding medical innovation to effect change in public health care policy, sponsor programs, meetings and studies utilizing the internet to make research accessible through blogs, studies, reports and podcasts.”.

When referring to its tasks, they were described as: “The communication of ideas that focus on understanding medical innovation to effect change in public health care policy.”.

  • The non-profit is operating legally in the state of NY.
  • The non-profit's address for the year 2020 is listed as 757 THIRD AVENUE 20TH FLOOR, NEW YORK, NY, 10017 in the filing.
  • The form submitted by the non-profit organization for 2020 reports 3 employees.
  • Is not a private foundation.
  • Expenses are between $500,000 and $1,000,000+.
  • Revenue is between $500,000 and $1,000,000+.
  • Revenue less expenses is -$19,181.
  • The organization has 4 independent voting members.
  • The organization was formed in 2006.
  • The organization pays $527,722 in salary, compensation, and benefits to its employees.
  • The organization pays $68,527 in fundraising expenses.

By donating on this page you are making an irrevocable contribution to Daffy Charitable Fund, a 501(c)(3) public charity, and a subsequent donation recommendation to the charity listed above, subject to our Member Agreement. Contributions are generally eligible for a charitable tax-deduction and a yearly consolidated receipt will be provided by Daffy. Processing fees may be applied and will reduce the value available to send to the end charity. The recipient organizations have not provided permission for this listing and have not reviewed the content.
Donations to organizations are distributed as soon as the donation is approved and the funds are available. In the rare event that Daffy is unable to fulfill the donation request to this charity, you will be notified and given the opportunity to choose another charity. This may occur if the charity is unresponsive or if the charity is no longer in good standing with regulatory authorities.